BEIJING/SHANGHAI, Feb 5 (Reuters) – A state-run Chinese research institute has applied for a patent on the use of Gilead Sciences’ experimental U.S. antiviral drug, which scientists think could provide treatment for the coronavirus that has killed hundreds and infected thousands. The Wuhan Institute of Virology of the China Academy of Sciences, based in the city where the outbreak is believed to have originated, said in a statement on Tuesday it applied to patent the use of Remdesivir, an antiviral drug developed by Gilead, to treat the virus. The Wuhan Institute of Virology did not respond to Reuters’ …read more
Source:: Yahoo Finance
